229 related articles for article (PubMed ID: 9177251)
1. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.
Rockwell P; O'Connor WJ; King K; Goldstein NI; Zhang LM; Stein CA
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6523-8. PubMed ID: 9177251
[TBL] [Abstract][Full Text] [Related]
2. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
Takahashi T; Shibuya M
Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
[TBL] [Abstract][Full Text] [Related]
3. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.
Kim YM; Hwang S; Kim YM; Pyun BJ; Kim TY; Lee ST; Gho YS; Kwon YG
J Biol Chem; 2002 Aug; 277(31):27872-9. PubMed ID: 12029087
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor.
Shi W; Siemann DW
Br J Cancer; 2002 Jul; 87(1):119-26. PubMed ID: 12085267
[TBL] [Abstract][Full Text] [Related]
5. Flk-1 as a target for tumor growth inhibition.
Strawn LM; McMahon G; App H; Schreck R; Kuchler WR; Longhi MP; Hui TH; Tang C; Levitzki A; Gazit A; Chen I; Keri G; Orfi L; Risau W; Flamme I; Ullrich A; Hirth KP; Shawver LK
Cancer Res; 1996 Aug; 56(15):3540-5. PubMed ID: 8758924
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
[TBL] [Abstract][Full Text] [Related]
8. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype.
Ortéga N; Jonca F; Vincent S; Favard C; Ruchoux MM; Plouët J
Am J Pathol; 1997 Nov; 151(5):1215-24. PubMed ID: 9358746
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII.
Endo A; Nagashima K; Kurose H; Mochizuki S; Matsuda M; Mochizuki N
J Biol Chem; 2002 Jun; 277(26):23747-54. PubMed ID: 11956190
[TBL] [Abstract][Full Text] [Related]
10. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
11. Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice.
Blaskovich MA; Lin Q; Delarue FL; Sun J; Park HS; Coppola D; Hamilton AD; Sebti SM
Nat Biotechnol; 2000 Oct; 18(10):1065-70. PubMed ID: 11017044
[TBL] [Abstract][Full Text] [Related]
12. Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor.
Liu L; Tsai JC; Aird WC
Blood; 2000 Sep; 96(5):1772-81. PubMed ID: 10961876
[TBL] [Abstract][Full Text] [Related]
13. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
14. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.
Price DJ; Miralem T; Jiang S; Steinberg R; Avraham H
Cell Growth Differ; 2001 Mar; 12(3):129-35. PubMed ID: 11306513
[TBL] [Abstract][Full Text] [Related]
15. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
16. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
Robinson GS; Pierce EA; Rook SL; Foley E; Webb R; Smith LE
Proc Natl Acad Sci U S A; 1996 May; 93(10):4851-6. PubMed ID: 8643492
[TBL] [Abstract][Full Text] [Related]
17. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
18. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix.
Guvakova MA; Yakubov LA; Vlodavsky I; Tonkinson JL; Stein CA
J Biol Chem; 1995 Feb; 270(6):2620-7. PubMed ID: 7852327
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
20. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
